Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2012

Open Access 01-12-2012 | Original investigation

High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels

Authors: Taiga Ichinomiya, Sungsam Cho, Ushio Higashijima, Shuhei Matsumoto, Takuji Maekawa, Koji Sumikawa

Published in: Cardiovascular Diabetology | Issue 1/2012

Login to get access

Abstract

Background

The current study was carried out to determine whether fasudil hydrochloride (fasudil), a Rho-kinase inhibitor, has myocardial postconditioning (PostC) activity under hyperglycemia as well as normoglycemia, and if so, whether the effects could be mediated by mitochondrial ATP-sensitive potassium (m-KATP) channels.

Methods

Male Sprague-Dawley rats were anesthetized with sodium pentobarbital. After opening the chest, all rats underwent 30-min coronary artery occlusion followed by 2-h reperfusion. The rats received low-dose (0.15 mg/kg) or high-dose (0.5 mg/kg) fasudil or diazoxide, an m-KATP channel opener, at 10 mg/kg, just before reperfusion under normoglycemic or hyperglycemic conditions. In another group, rats received 5-hydroxydecanoic acid (5HD), an m-KATP channel blocker, at 10 mg/kg, before high-dose fasudil. Myocardial infarct size was expressed as a percentage of area at risk (AAR).

Results

Under normoglycemia, low-dose and high-dose fasudil and diazoxide reduced myocardial infarct size (23 ± 8%, 21 ± 9% and 21 ± 10% of AAR, respectively) compared with that in the control (42 ± 7%). Under hyperglycemia, low-dose fasudil (40 ± 11%) and diazoxide (44 ± 14%) could not exert this beneficial effect, but high-dose fasudil reduced myocardial infarct size in the same manner as under normoglycemia (21 ± 13%). 5HD prevented fasudil-induced reduction of myocardial infarct size (42 ± 13%).

Conclusion

Fasudil induces PostC against myocardial infarction via activation of m-KATP channels in the rat. Although hyperglycemia attenuates the PostC, high-dose fasudil can restore cardioprotection.
Appendix
Available only for authorised users
Literature
2.
go back to reference Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H: Thadani U; Fasudil Study Group: Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005, 46: 1803-1811. 10.1016/j.jacc.2005.07.047.CrossRefPubMed Vicari RM, Chaitman B, Keefe D, Smith WB, Chrysant SG, Tonkon MJ, Bittar N, Weiss RJ, Morales-Ballejo H: Thadani U; Fasudil Study Group: Efficacy and safety of fasudil in patients with stable angina: a double-blind, placebo-controlled, phase 2 trial. J Am Coll Cardiol. 2005, 46: 1803-1811. 10.1016/j.jacc.2005.07.047.CrossRefPubMed
3.
go back to reference Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H: Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina. J Cardiovasc Pharmacol. 2007, 49: 117-121. 10.1097/FJC.0b013e31802ef532.CrossRefPubMed Fukumoto Y, Mohri M, Inokuchi K, Ito A, Hirakawa Y, Masumoto A, Hirooka Y, Takeshita A, Shimokawa H: Anti-ischemic effects of fasudil, a specific Rho-kinase inhibitor, in patients with stable effort angina. J Cardiovasc Pharmacol. 2007, 49: 117-121. 10.1097/FJC.0b013e31802ef532.CrossRefPubMed
4.
go back to reference Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK: Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004, 24: 1842-1847. 10.1161/01.ATV.0000142813.33538.82.PubMedCentralCrossRefPubMed Wolfrum S, Dendorfer A, Rikitake Y, Stalker TJ, Gong Y, Scalia R, Dominiak P, Liao JK: Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004, 24: 1842-1847. 10.1161/01.ATV.0000142813.33538.82.PubMedCentralCrossRefPubMed
5.
go back to reference Hamid SA, Bower HS, Baxter GF: Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Am J Physiol Heart Circ Physiol. 2007, 292: H2598-H2606. 10.1152/ajpheart.01393.2006.CrossRefPubMed Hamid SA, Bower HS, Baxter GF: Rho kinase activation plays a major role as a mediator of irreversible injury in reperfused myocardium. Am J Physiol Heart Circ Physiol. 2007, 292: H2598-H2606. 10.1152/ajpheart.01393.2006.CrossRefPubMed
6.
go back to reference Zhao JL, Yang YJ, Pei WD, Sun YH, You SJ, Gao RL: Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase. Int J Cardiol. 2009, 133: 179-184. 10.1016/j.ijcard.2007.12.024.CrossRefPubMed Zhao JL, Yang YJ, Pei WD, Sun YH, You SJ, Gao RL: Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase. Int J Cardiol. 2009, 133: 179-184. 10.1016/j.ijcard.2007.12.024.CrossRefPubMed
7.
go back to reference Ergelen M, Uyarel H, Cicek G, Isik T, Osmonov D, Gunaydin ZY, Bozbay M, Turer A, Gul M, Abanonu GB, Ilhan E: Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both?. Acta Cardiol. 2010, 65: 415-423.PubMed Ergelen M, Uyarel H, Cicek G, Isik T, Osmonov D, Gunaydin ZY, Bozbay M, Turer A, Gul M, Abanonu GB, Ilhan E: Which is worst in patients undergoing primary angioplasty for acute myocardial infarction? Hyperglycaemia? Diabetes mellitus? Or both?. Acta Cardiol. 2010, 65: 415-423.PubMed
8.
go back to reference Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9.CrossRefPubMed Capes SE, Hunt D, Malmberg K, Gerstein HC: Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000, 355: 773-778. 10.1016/S0140-6736(99)08415-9.CrossRefPubMed
9.
go back to reference Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringa HH, Dunkelgrun M, Bax JJ, Klein J, Poldermans D: Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007, 156: 137-142. 10.1530/eje.1.02321.CrossRefPubMed Noordzij PG, Boersma E, Schreiner F, Kertai MD, Feringa HH, Dunkelgrun M, Bax JJ, Klein J, Poldermans D: Increased preoperative glucose levels are associated with perioperative mortality in patients undergoing noncardiac, nonvascular surgery. Eur J Endocrinol. 2007, 156: 137-142. 10.1530/eje.1.02321.CrossRefPubMed
10.
go back to reference Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B: Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth. 2008, 100: 465-471. 10.1093/bja/aen022.CrossRefPubMed Huhn R, Heinen A, Weber NC, Hollmann MW, Schlack W, Preckel B: Hyperglycaemia blocks sevoflurane-induced postconditioning in the rat heart in vivo: cardioprotection can be restored by blocking the mitochondrial permeability transition pore. Br J Anaesth. 2008, 100: 465-471. 10.1093/bja/aen022.CrossRefPubMed
11.
go back to reference Raphael J, Gozal Y, Navot N, Zuo Z: Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol. 2010, 55: 348-357. 10.1097/FJC.0b013e3181d26583.CrossRefPubMed Raphael J, Gozal Y, Navot N, Zuo Z: Hyperglycemia inhibits anesthetic-induced postconditioning in the rabbit heart via modulation of phosphatidylinositol-3-kinase/Akt and endothelial nitric oxide synthase signaling. J Cardiovasc Pharmacol. 2010, 55: 348-357. 10.1097/FJC.0b013e3181d26583.CrossRefPubMed
12.
go back to reference Kersten JR, Montgomery MW, Ghassemi T, Gross ER, Toller WG, Pagel PS, Warltier DC: Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 2001, 280: H1744-H1750.PubMed Kersten JR, Montgomery MW, Ghassemi T, Gross ER, Toller WG, Pagel PS, Warltier DC: Diabetes and hyperglycemia impair activation of mitochondrial K(ATP) channels. Am J Physiol Heart Circ Physiol. 2001, 280: H1744-H1750.PubMed
13.
go back to reference Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002, 96: 183-188. 10.1097/00000542-200201000-00032.CrossRefPubMed Kehl F, Krolikowski JG, Mraovic B, Pagel PS, Warltier DC, Kersten JR: Hyperglycemia prevents isoflurane-induced preconditioning against myocardial infarction. Anesthesiology. 2002, 96: 183-188. 10.1097/00000542-200201000-00032.CrossRefPubMed
14.
go back to reference LaDisa JF, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol. 2004, 287: H601-H607. 10.1152/ajpheart.00122.2004.CrossRefPubMed LaDisa JF, Krolikowski JG, Pagel PS, Warltier DC, Kersten JR: Cardioprotection by glucose-insulin-potassium: dependence on KATP channel opening and blood glucose concentration before ischemia. Am J Physiol Heart Circ Physiol. 2004, 287: H601-H607. 10.1152/ajpheart.00122.2004.CrossRefPubMed
15.
go back to reference Kim HS, Kim SY, Kwak YL, Hwang KC, Shim YH: Hyperglycemia Attenuates Myocardial Preconditioning of Remifentanil. J Surg Res. 2011. Kim HS, Kim SY, Kwak YL, Hwang KC, Shim YH: Hyperglycemia Attenuates Myocardial Preconditioning of Remifentanil. J Surg Res. 2011.
16.
go back to reference Wong VW, Mardini M, Cheung NW, Mihailidou AS: High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia. J Diabetes Complications. 2011, 25: 122-128. 10.1016/j.jdiacomp.2010.01.001.CrossRefPubMed Wong VW, Mardini M, Cheung NW, Mihailidou AS: High-dose insulin in experimental myocardial infarction in rabbits: protection against effects of hyperglycaemia. J Diabetes Complications. 2011, 25: 122-128. 10.1016/j.jdiacomp.2010.01.001.CrossRefPubMed
17.
go back to reference Balakumar P, Singh H, Singh M, Anand-Srivastava MB: The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res. 2009, 60: 18-23. 10.1016/j.phrs.2009.03.002.CrossRefPubMed Balakumar P, Singh H, Singh M, Anand-Srivastava MB: The impairment of preconditioning-mediated cardioprotection in pathological conditions. Pharmacol Res. 2009, 60: 18-23. 10.1016/j.phrs.2009.03.002.CrossRefPubMed
18.
go back to reference Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR: N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology. 2003, 98: 1384-1390. 10.1097/00000542-200306000-00013.CrossRefPubMed Kehl F, Krolikowski JG, Weihrauch D, Pagel PS, Warltier DC, Kersten JR: N-acetylcysteine restores isoflurane-induced preconditioning against myocardial infarction during hyperglycemia. Anesthesiology. 2003, 98: 1384-1390. 10.1097/00000542-200306000-00013.CrossRefPubMed
19.
go back to reference Matsumoto S, Cho S, Tosaka S, Ureshino H, Maekawa T, Hara T, Sumikawa K: Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway. Cardiovasc Drugs Ther. 2009, 23: 263-270. 10.1007/s10557-009-6184-5.CrossRefPubMed Matsumoto S, Cho S, Tosaka S, Ureshino H, Maekawa T, Hara T, Sumikawa K: Pharmacological preconditioning in type 2 diabetic rat hearts: the roles of mitochondrial ATP-sensitive potassium channels and the phosphatidylinositol 3-kinase-Akt pathway. Cardiovasc Drugs Ther. 2009, 23: 263-270. 10.1007/s10557-009-6184-5.CrossRefPubMed
20.
go back to reference Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, Nakashima M: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992, 76: 571-577.PubMed Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, Nagata I, Kikuchi H, Takemae T, Hidaka H, Nakashima M: Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Results of a prospective placebo-controlled double-blind trial. J Neurosurg. 1992, 76: 571-577.PubMed
21.
go back to reference Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology. 2004, 100: 532-539. 10.1097/00000542-200403000-00011.CrossRefPubMed Ludwig LM, Weihrauch D, Kersten JR, Pagel PS, Warltier DC: Protein kinase C translocation and Src protein tyrosine kinase activation mediate isoflurane-induced preconditioning in vivo: potential downstream targets of mitochondrial adenosine triphosphate-sensitive potassium channels and reactive oxygen species. Anesthesiology. 2004, 100: 532-539. 10.1097/00000542-200403000-00011.CrossRefPubMed
22.
go back to reference Shibuya M, Hirai S, Seto M, Satoh S: Ohtomo E; Fasudil Ischemic Stroke Study Group: Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci. 2005, 238: 31-39. 10.1016/j.jns.2005.06.003.CrossRefPubMed Shibuya M, Hirai S, Seto M, Satoh S: Ohtomo E; Fasudil Ischemic Stroke Study Group: Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial. J Neurol Sci. 2005, 238: 31-39. 10.1016/j.jns.2005.06.003.CrossRefPubMed
23.
go back to reference Matsumoto S, Cho S, Tosaka S, Higashijima U, Maekawa T, Hara T, Sumikawa K: Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts. Cardiovasc Diabetol. 2012, 11: 4-10.1186/1475-2840-11-4.PubMedCentralCrossRefPubMed Matsumoto S, Cho S, Tosaka S, Higashijima U, Maekawa T, Hara T, Sumikawa K: Hyperglycemia raises the threshold of levosimendan- but not milrinone-induced postconditioning in rat hearts. Cardiovasc Diabetol. 2012, 11: 4-10.1186/1475-2840-11-4.PubMedCentralCrossRefPubMed
24.
go back to reference Hönisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C: Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol. 2010, 105: 155-167. 10.1007/s00395-009-0064-9.CrossRefPubMed Hönisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C: Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol. 2010, 105: 155-167. 10.1007/s00395-009-0064-9.CrossRefPubMed
25.
go back to reference Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H: Kitamura S; J-WIND investigators: Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007, 370: 1483-1493. 10.1016/S0140-6736(07)61634-1.CrossRefPubMed Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, Seguchi O, Myoishi M, Minamino T, Ohara T, Nagai Y, Nanto S, Watanabe K, Fukuzawa S, Hirayama A, Nakamura N, Kimura K, Fujii K, Ishihara M, Saito Y, Tomoike H: Kitamura S; J-WIND investigators: Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007, 370: 1483-1493. 10.1016/S0140-6736(07)61634-1.CrossRefPubMed
26.
go back to reference Imagawa J, Baxter GF, Yellon DM: Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol. 1998, 31: 74-79. 10.1097/00005344-199801000-00011.CrossRefPubMed Imagawa J, Baxter GF, Yellon DM: Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. J Cardiovasc Pharmacol. 1998, 31: 74-79. 10.1097/00005344-199801000-00011.CrossRefPubMed
27.
go back to reference Sumi S, Kobayashi H, Yasuda S, Iwasa M, Yamaki T, Yamada Y, Ushikoshi H, Hattori A, Aoyama T, Nishigaki K, Takemura G, Minatoguchi S: Postconditioning effect of granulocyte colony-stimulating factor is mediated through activation of risk pathway and opening of the mitochondrial KATP channels. Am J Physiol Heart Circ Physiol. 2010, 299: H1174-H1182. 10.1152/ajpheart.00116.2010.CrossRefPubMed Sumi S, Kobayashi H, Yasuda S, Iwasa M, Yamaki T, Yamada Y, Ushikoshi H, Hattori A, Aoyama T, Nishigaki K, Takemura G, Minatoguchi S: Postconditioning effect of granulocyte colony-stimulating factor is mediated through activation of risk pathway and opening of the mitochondrial KATP channels. Am J Physiol Heart Circ Physiol. 2010, 299: H1174-H1182. 10.1152/ajpheart.00116.2010.CrossRefPubMed
28.
go back to reference Hönisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C: Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol. 2010, 105: 155-167. 10.1007/s00395-009-0064-9.CrossRefPubMed Hönisch A, Theuring N, Ebner B, Wagner C, Strasser RH, Weinbrenner C: Postconditioning with levosimendan reduces the infarct size involving the PI3K pathway and KATP-channel activation but is independent of PDE-III inhibition. Basic Res Cardiol. 2010, 105: 155-167. 10.1007/s00395-009-0064-9.CrossRefPubMed
29.
go back to reference Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH: Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology. 2011, 114: 1364-1372. 10.1097/ALN.0b013e31820efafd.CrossRefPubMed Drenger B, Ostrovsky IA, Barak M, Nechemia-Arbely Y, Ziv E, Axelrod JH: Diabetes blockade of sevoflurane postconditioning is not restored by insulin in the rat heart: phosphorylated signal transducer and activator of transcription 3- and phosphatidylinositol 3-kinase-mediated inhibition. Anesthesiology. 2011, 114: 1364-1372. 10.1097/ALN.0b013e31820efafd.CrossRefPubMed
30.
go back to reference Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W: The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg. 2005, 101: 1252-1260. 10.1213/01.ANE.0000181336.96511.32.CrossRefPubMed Obal D, Dettwiler S, Favoccia C, Scharbatke H, Preckel B, Schlack W: The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth Analg. 2005, 101: 1252-1260. 10.1213/01.ANE.0000181336.96511.32.CrossRefPubMed
31.
go back to reference Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS: Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg. 2005, 101: 1590-1596.CrossRefPubMed Krolikowski JG, Bienengraeber M, Weihrauch D, Warltier DC, Kersten JR, Pagel PS: Inhibition of mitochondrial permeability transition enhances isoflurane-induced cardioprotection during early reperfusion: the role of mitochondrial KATP channels. Anesth Analg. 2005, 101: 1590-1596.CrossRefPubMed
32.
go back to reference Wang J, Liu H, Chen B, Li Q, Huang X, Wang L, Guo X, Huang Q: RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Cardiovasc Diabetol. 2012, 11: 7-10.1186/1475-2840-11-7.PubMedCentralCrossRefPubMed Wang J, Liu H, Chen B, Li Q, Huang X, Wang L, Guo X, Huang Q: RhoA/ROCK-dependent moesin phosphorylation regulates AGE-induced endothelial cellular response. Cardiovasc Diabetol. 2012, 11: 7-10.1186/1475-2840-11-7.PubMedCentralCrossRefPubMed
33.
go back to reference Zhang J, Bian HJ, Li XX, Liu XB, Sun JP, Li N, Zhang Y, Ji XP: ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning. Mol Med. 2010, 16: 307-315.PubMed Zhang J, Bian HJ, Li XX, Liu XB, Sun JP, Li N, Zhang Y, Ji XP: ERK-MAPK signaling opposes rho-kinase to reduce cardiomyocyte apoptosis in heart ischemic preconditioning. Mol Med. 2010, 16: 307-315.PubMed
34.
go back to reference Rikitake Y, Liao JK: Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation. 2005, 111: 3261-3268. 10.1161/CIRCULATIONAHA.105.534024.PubMedCentralCrossRefPubMed Rikitake Y, Liao JK: Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells. Circulation. 2005, 111: 3261-3268. 10.1161/CIRCULATIONAHA.105.534024.PubMedCentralCrossRefPubMed
35.
go back to reference Iwasaki H, Okamoto R, Kato S, Konishi K, Mizutani H, Yamada N, Isaka N, Nakano T, Ito M: High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-kappaB activation in bovine aortic endothelial cells. Atherosclerosis. 2008, 196: 22-28. 10.1016/j.atherosclerosis.2006.12.025.CrossRefPubMed Iwasaki H, Okamoto R, Kato S, Konishi K, Mizutani H, Yamada N, Isaka N, Nakano T, Ito M: High glucose induces plasminogen activator inhibitor-1 expression through Rho/Rho-kinase-mediated NF-kappaB activation in bovine aortic endothelial cells. Atherosclerosis. 2008, 196: 22-28. 10.1016/j.atherosclerosis.2006.12.025.CrossRefPubMed
36.
go back to reference Axelsson J, Rippe A, Rippe B: Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats. Am J Physiol Renal Physiol. 2010, 298: F1306-F1312. 10.1152/ajprenal.00710.2009.CrossRefPubMed Axelsson J, Rippe A, Rippe B: Acute hyperglycemia induces rapid, reversible increases in glomerular permeability in nondiabetic rats. Am J Physiol Renal Physiol. 2010, 298: F1306-F1312. 10.1152/ajprenal.00710.2009.CrossRefPubMed
37.
go back to reference Zhou H, Zhang KX, Li YJ, Guo BY, Wang M, Wang M: Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts. Clin Exp Pharmacol Physiol. 2011, 38: 387-394. 10.1111/j.1440-1681.2011.05523.x.CrossRefPubMed Zhou H, Zhang KX, Li YJ, Guo BY, Wang M, Wang M: Fasudil hydrochloride hydrate, a Rho-kinase inhibitor, suppresses high glucose-induced proliferation and collagen synthesis in rat cardiac fibroblasts. Clin Exp Pharmacol Physiol. 2011, 38: 387-394. 10.1111/j.1440-1681.2011.05523.x.CrossRefPubMed
38.
go back to reference Przyklenk K, Maynard M, Greiner DL, Whittaker P: Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal. 2011, 14: 781-790. 10.1089/ars.2010.3343.PubMedCentralCrossRefPubMed Przyklenk K, Maynard M, Greiner DL, Whittaker P: Cardioprotection with postconditioning: loss of efficacy in murine models of type-2 and type-1 diabetes. Antioxid Redox Signal. 2011, 14: 781-790. 10.1089/ars.2010.3343.PubMedCentralCrossRefPubMed
39.
go back to reference Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM: Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005, 54: 2360-2364. 10.2337/diabetes.54.8.2360.CrossRefPubMed Tsang A, Hausenloy DJ, Mocanu MM, Carr RD, Yellon DM: Preconditioning the diabetic heart: the importance of Akt phosphorylation. Diabetes. 2005, 54: 2360-2364. 10.2337/diabetes.54.8.2360.CrossRefPubMed
40.
go back to reference Shi-Ting W, Mang-Hua X, Wen-Ting C, Feng-Hou G, Zhu-Ying G: Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type 1 diabetes rat heart. Biomed Pharmacother. 2011, 1: 56-60. Shi-Ting W, Mang-Hua X, Wen-Ting C, Feng-Hou G, Zhu-Ying G: Study on tolerance to ischemia-reperfusion injury and protection of ischemic preconditioning of type 1 diabetes rat heart. Biomed Pharmacother. 2011, 1: 56-60.
41.
go back to reference Marinovic J, Bosnjak ZJ, Stadnicka A: Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology. 2006, 105: 98-104. 10.1097/00000542-200607000-00018.CrossRefPubMed Marinovic J, Bosnjak ZJ, Stadnicka A: Distinct roles for sarcolemmal and mitochondrial adenosine triphosphate-sensitive potassium channels in isoflurane-induced protection against oxidative stress. Anesthesiology. 2006, 105: 98-104. 10.1097/00000542-200607000-00018.CrossRefPubMed
42.
go back to reference Yang MK, Lee SH, Seo HW, Yi KY, Yoo SE, Lee BH, Chung HJ, Won HS, Lee CS, Kwon SH, Choi WS, Shin HS: KR-31761, a novel K + (ATP)-channel opener, exerts cardioprotective effects by opening both mitochondrial K + (ATP) and Sarcolemmal K + (ATP) channels in rat models of ischemia/reperfusion-induced heart injury. J Pharmacol Sci. 2009, 109: 222-232. 10.1254/jphs.08132FP.CrossRefPubMed Yang MK, Lee SH, Seo HW, Yi KY, Yoo SE, Lee BH, Chung HJ, Won HS, Lee CS, Kwon SH, Choi WS, Shin HS: KR-31761, a novel K + (ATP)-channel opener, exerts cardioprotective effects by opening both mitochondrial K + (ATP) and Sarcolemmal K + (ATP) channels in rat models of ischemia/reperfusion-induced heart injury. J Pharmacol Sci. 2009, 109: 222-232. 10.1254/jphs.08132FP.CrossRefPubMed
43.
go back to reference Chen ZC, Cheng YZ, Chen LJ, Cheng KC, Li Y, Cheng J: Increase of ATP-sensitive potassium (KATP) channels in the heart of type-1 diabetic rats. Cardiovasc Diabetol. 2012, 11: 8-10.1186/1475-2840-11-8.PubMedCentralCrossRefPubMed Chen ZC, Cheng YZ, Chen LJ, Cheng KC, Li Y, Cheng J: Increase of ATP-sensitive potassium (KATP) channels in the heart of type-1 diabetic rats. Cardiovasc Diabetol. 2012, 11: 8-10.1186/1475-2840-11-8.PubMedCentralCrossRefPubMed
Metadata
Title
High-dose fasudil preserves postconditioning against myocardial infarction under hyperglycemia in rats: role of mitochondrial KATP channels
Authors
Taiga Ichinomiya
Sungsam Cho
Ushio Higashijima
Shuhei Matsumoto
Takuji Maekawa
Koji Sumikawa
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2012
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-11-28

Other articles of this Issue 1/2012

Cardiovascular Diabetology 1/2012 Go to the issue